Company / Cost of Revenue
OMEROS CORP Cost of Revenue History
FY2015-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$902.0K
FY2020
5-year range
$902.0K / $902.0K
FY2016-FY2020
Trend
+4.3%
vs FY2019
Sector context
#80 of 85
Health Care
What the data says
Among 85 Health Care companies, OMEROS CORP is in the top 6% for cost of revenue. Increased from $512,000 to $902,000 over the past 2 years.
Based on SEC 10-K filings.
$902,000 in FY2020 with a 3-year CAGR of -5.8%.
Increased from $512,000 to $902,000 over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 85This company $902.0K Sector average $2.0B
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -5.8%, indicating a declining trend.
- In FY2020, cost of revenue increased 4.3% year-over-year.
- Ranks #80 out of 85 companies in the Health Care sector.
- Peak cost of revenue was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $902.0K | +4.3% |
| FY2019 | $865.0K | +68.9% |
| FY2018 | $512.0K | -52.5% |
| FY2017 | $1.1M | -23.7% |
| FY2016 | $1.4M | - |
| FY2015 | $0 | - |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026